Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-cancer analysis revealed prognosis value and immunological relevance of RAMPs

18 Jan 2024

Abstract excerpt

Whether receptor activity-modifying proteins (RAMPs) play a key role in human cancer prognosis and immunity remains unknown. We used data from the public databases, The Cancer Genome Atlas, Therapeutically Applicable Research to Generate Effective Treatments, and the Genotype-Tissue Expression project. We utilized bioinformatics methods, R software, and a variety of online databases to analyze RAMPs. In general,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38317990
DOI: 10.1016/j.heliyon.2024.e24849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer analysis revealed prognosis value and immunological relevance of RAMPsPMID 38317990Read ↗

Pan-Cancer Analysis of Molecular Characteristics and Oncogenic Role of PRMT5 in Human CancersSemantic proximity Read ↗

Pan-cancer RNA editing activity reveals complex editing functions and cancer immunotherapy biomarkersSemantic proximity Read ↗

Comprehensive analysis of predictive significance of PRR11 in glioma at multiple-datasets and single-cell sequencing levelsSemantic proximity Read ↗

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancerSemantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Pan-cancer analysis reveals potential for synergy between SERPINA1 molecular targeting and macrophage-related immunotherapySemantic proximity Read ↗

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerSemantic proximity Read ↗

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancerSemantic proximity Read ↗

Genomic Landscape and Immunological Profile of Glioblastoma in East Asian PatientsSemantic proximity Read ↗

An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.Semantic proximity Read ↗

Systematic identification of cancer-specific MHC-binding peptides with RAVENSemantic proximity Read ↗

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.